GGrantIndex
← Leaderboards

Ricardo S Osorio

New York University School Of Medicine

Google Scholar ↗PubMed ↗ORCID ↗
$22,589,057
Attributed
$44,529,917
Total exposure
13
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $9.5M · FY2013–25
$10M$7.5M$5M$2.5M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$44,529,917 · 13

By mechanism

R01$33,230,816 · 8
RF1$9,466,491 · 1
R21$1,832,610 · 4

Top collaborators

Most similar at New York University School Of Medicine

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos”

Research focus

Alzheimer&AposS DiseaseCognitivePositron-Emission TomographyImpaired CognitionElderlyMemoryBrainPrevalenceCognitionS Disease RiskSleepAmyloid Beta-ProteinTau ProteinsParticipantAmyloidSleep DisturbancesSleep DisordersCerebrospinal FluidBiological MarkersSeveritiesCohortDementiaMonitor

Grant awards (43)

Effects of Successful OSA TreatmENT on Memory and AD BIomarkers in Older AduLts (ESSENTIAL)$9,466,491
RF1 · FY2025 · AG
Effects of Successful OSA TreatmENT on Memory and AD BIomarkers in Older AduLts (ESSENTIAL)$3,792,731
R01 · FY2024 · AG
Impact of sleep apnea and its treatment on memory and tau accumulation in the brain$823,342
R01 · FY2024 · AG
Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD)$808,272
R01 · FY2024 · AG
Brain Effects of Lifetime Racial/Ethnic Discrimination on the LC-NE Function and the Risk for Alzheimer's Disease$804,442
R01 · FY2024 · AG
Effects of Successful OSA TreatmENT on Memory and AD BIomarkers in Older AduLts (ESSENTIAL)$3,611,262
R01 · FY2023 · AG
Brain Effects of Lifetime Racial/Ethnic Discrimination on the LC-NE Function and the Risk for Alzheimer's Disease$824,767
R01 · FY2023 · AG
Impact of sleep apnea and its treatment on memory and tau accumulation in the brain$821,288
R01 · FY2023 · AG
Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD)$808,272
R01 · FY2023 · AG
Slow wave sleep (SWS) and the effect of African ancestry on amyloid burden, a longitudinal study$1,300,400
R01 · FY2022 · AG · contact PI
Brain Effects of Lifetime Racial/Ethnic Discrimination on the LC-NE Function and the Risk for Alzheimer's Disease$836,123
R01 · FY2022 · AG
Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD)$817,933
R01 · FY2022 · AG
Sleep Aging and Risk for Alzheimer's disease-Resubmission-1$804,788
R01 · FY2022 · AG · contact PI
Impact of sleep apnea and its treatment on memory and tau accumulation in the brain$660,400
R01 · FY2022 · AG
Slow wave sleep (SWS) and the effect of African ancestry on amyloid burden, a longitudinal study$1,299,442
R01 · FY2021 · AG · contact PI
Brain Effects of Lifetime Racial/Ethnic Discrimination on the LC-NE Function and the Risk for Alzheimer's Disease$847,141
R01 · FY2021 · AG
Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD)$821,502
R01 · FY2021 · AG
Sleep Aging and Risk for Alzheimer's disease-Resubmission-1$807,954
R01 · FY2021 · AG · contact PI
Impact of sleep apnea and its treatment on memory and tau accumulation in the brain$659,380
R01 · FY2021 · AG
Locus-coeruleus function in normal elderly and AD risk (LEAD)$254,250
R21 · FY2021 · AG · contact PI
Mechanisms of sleep deficiency and effects on brain injury and neurocognitive functions among older blacks$110,515
R01 · FY2021 · AG
Slow wave sleep (SWS) and the effect of African ancestry on amyloid burden, a longitudinal study$1,337,074
R01 · FY2020 · AG · contact PI
Sleep Aging and Risk for Alzheimer's disease-Resubmission-1$940,237
R01 · FY2020 · AG · contact PI
Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD)$873,715
R01 · FY2020 · AG
Mechanisms of sleep deficiency and effects on brain injury and neurocognitive functions among older blacks$833,876
R01 · FY2020 · AG
Impact of sleep apnea and its treatment on memory and tau accumulation in the brain$700,238
R01 · FY2020 · AG
Neuroenergetic Adaptations in Alzheimer's Disease: Implications on Amyloid Burden and Cognition$254,250
R21 · FY2020 · AG
Locus-coeruleus function in normal elderly and AD risk (LEAD)$229,250
R21 · FY2020 · AG · contact PI
Slow wave sleep (SWS) and the effect of African ancestry on amyloid burden, a longitudinal study$1,380,557
R01 · FY2019 · AG · contact PI
Sleep Aging and Risk for Alzheimer's disease-Resubmission-1$833,431
R01 · FY2019 · AG · contact PI
Neuroenergetic Adaptations in Alzheimer's Disease: Implications on Amyloid Burden and Cognition$211,875
R21 · FY2019 · AG
Sleep Aging and Risk for Alzheimer's disease-Resubmission-1$115,316
R01 · FY2019 · AG · contact PI
Slow wave sleep (SWS) and the effect of African ancestry on amyloid burden, a longitudinal study$1,410,492
R01 · FY2018 · AG · contact PI
Sleep Aging and Risk for Alzheimer's disease-Resubmission-1$858,434
R01 · FY2018 · AG · contact PI
Orexin (hypocretin) and tau pathology in cognitively normal elderly: a new prevention strategy for Alzheimer's disease$184,453
R21 · FY2018 · AG · contact PI
Orexin (hypocretin) and tau pathology in cognitively normal elderly: a new prevention strategy for Alzheimer's disease$244,532
R21 · FY2017 · AG · contact PI
Sleep Disordered Breathing in normal elderly and risk for Alzheimers Disease$696,676
R01 · FY2016 · HL · contact PI
Brain Sleep Clearance of Amyloid-Beta Peptides Study (Brain SCRAPS)$204,815
R21 · FY2016 · AG · contact PI
Sleep Disordered Breathing in normal elderly and risk for Alzheimers Disease$756,611
R01 · FY2015 · HL · contact PI
Brain Sleep Clearance of Amyloid-Beta Peptides Study (Brain SCRAPS)$249,185
R21 · FY2015 · AG · contact PI
Sleep Disordered Breathing in normal elderly and risk for Alzheimers Disease$610,606
R01 · FY2014 · HL · contact PI
Sleep Disordered Breathing in normal elderly and risk for Alzheimers Disease$61,020
R01 · FY2014 · HL · contact PI
Sleep Disordered Breathing in normal elderly and risk for Alzheimers Disease$562,579
R01 · FY2013 · HL · contact PI